Table:
begin	end	state
1	11	cytoplasmic
12	31	transmembrane
32	36	non-cytoplasmic
37	59	transmembrane
60	65	cytoplasmic
66	85	transmembrane
86	90	non-cytoplasmic
91	111	transmembrane
112	119	cytoplasmic
120	142	transmembrane
143	161	non-cytoplasmic
162	184	transmembrane
185	213	cytoplasmic
214	235	transmembrane
236	240	non-cytoplasmic
241	261	transmembrane
262	266	cytoplasmic
267	286	transmembrane
287	295	non-cytoplasmic
296	320	transmembrane
321	337	cytoplasmic

Input:
>SM_b21017 FitnessBrowser__Smeli:SM_b21017
MKKLIFRWETALFAMLVAELLIFGLVNPRFLNLTNLIYGTSDFVQIGIVALPLTLVIIAG
GIDVSFASVIGLTAIMFGVATFYGVPLPLSILLALVTGALCGLLNATVIHLSKIQPLVVT
LGSLYLFQGTATVASGLVGAGGYEGIGNFPEAFNAFGYAEFLGLPAPLALFLALSLVLIV
LLHFTRFGRTVFLSGQSERAAHFAGIPVGRVQTFTYVITGVSAAIAGLVMSAYFGSARVD
LGSATLLPAVTAAVLGGASIYGGQGSILGTLLATFVIGYLQQGLQAAGVPSQISSALSGG
LLVVAVALRHASAMLADFIAVARQQRQNRVAVTSGGE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server